Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program. (Record no. 29424260)

MARC details
000 -LEADER
fixed length control field 01472 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518024846.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2374-2445
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1001/jamaoncol.2018.7002
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Feit, Noah Z
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200210
245 00 - TITLE STATEMENT
Title Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. JAMA oncology
Date of publication, distribution, etc. Apr 2019
300 ## - PHYSICAL DESCRIPTION
Extent 570-572 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Compassionate Use Trials
General subdivision statistics & numerical data
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs, Investigational
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Program Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States Food and Drug Administration
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goldman, Debra A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Smith, Evan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Deighan, Jenny
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Iasonos, Alexia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zivanovic, Oliver
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hyman, David M
773 0# - HOST ITEM ENTRY
Title JAMA oncology
Related parts vol. 5
-- no. 4
-- p. 570-572
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1001/jamaoncol.2018.7002">https://doi.org/10.1001/jamaoncol.2018.7002</a>
Public note Available from publisher's website

No items available.